Sei Investments Co. Has $60.77 Million Position in Becton, Dickinson and Company (NYSE:BDX)

Sei Investments Co. lifted its stake in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 12.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 267,861 shares of the medical instruments supplier's stock after acquiring an additional 30,547 shares during the period. Sei Investments Co. owned 0.09% of Becton, Dickinson and Company worth $60,766,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. First Eagle Investment Management LLC lifted its position in Becton, Dickinson and Company by 31.4% in the fourth quarter. First Eagle Investment Management LLC now owns 4,426,022 shares of the medical instruments supplier's stock worth $1,004,132,000 after purchasing an additional 1,057,879 shares during the period. Raymond James Financial Inc. acquired a new position in Becton, Dickinson and Company during the fourth quarter worth about $181,279,000. Nordea Investment Management AB raised its position in Becton, Dickinson and Company by 31.0% in the fourth quarter. Nordea Investment Management AB now owns 2,844,566 shares of the medical instruments supplier's stock worth $647,082,000 after acquiring an additional 673,568 shares in the last quarter. The Manufacturers Life Insurance Company lifted its holdings in Becton, Dickinson and Company by 62.2% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 1,107,317 shares of the medical instruments supplier's stock valued at $266,974,000 after acquiring an additional 424,487 shares during the last quarter. Finally, Diamond Hill Capital Management Inc. boosted its position in shares of Becton, Dickinson and Company by 24.3% during the 4th quarter. Diamond Hill Capital Management Inc. now owns 1,782,894 shares of the medical instruments supplier's stock valued at $404,485,000 after purchasing an additional 348,335 shares in the last quarter. 86.97% of the stock is currently owned by institutional investors.

Remove Ads

Insider Activity at Becton, Dickinson and Company

In related news, EVP Richard Byrd sold 1,940 shares of the stock in a transaction that occurred on Wednesday, March 12th. The stock was sold at an average price of $224.91, for a total value of $436,325.40. Following the transaction, the executive vice president now owns 7,411 shares in the company, valued at approximately $1,666,808.01. This represents a 20.75 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Bertram L. Scott sold 700 shares of Becton, Dickinson and Company stock in a transaction that occurred on Wednesday, February 12th. The shares were sold at an average price of $227.99, for a total transaction of $159,593.00. Following the completion of the sale, the director now owns 36,033 shares of the company's stock, valued at $8,215,163.67. This trade represents a 1.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 4,984 shares of company stock valued at $1,147,865. Insiders own 0.36% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the stock. StockNews.com lowered shares of Becton, Dickinson and Company from a "buy" rating to a "hold" rating in a research note on Tuesday. Barclays increased their price objective on Becton, Dickinson and Company from $278.00 to $279.00 and gave the company an "overweight" rating in a research report on Friday, February 14th. Finally, Piper Sandler boosted their target price on Becton, Dickinson and Company from $275.00 to $280.00 and gave the stock an "overweight" rating in a research report on Tuesday, January 28th. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $278.29.

Becton, Dickinson and Company Stock Up 0.3 %

Becton, Dickinson and Company stock traded up $0.76 during mid-day trading on Thursday, hitting $228.76. The company's stock had a trading volume of 1,602,261 shares, compared to its average volume of 1,535,158. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.13 and a quick ratio of 0.63. Becton, Dickinson and Company has a 52-week low of $218.75 and a 52-week high of $251.99. The firm's 50 day moving average is $232.18 and its 200 day moving average is $231.85. The company has a market cap of $65.68 billion, a PE ratio of 38.00, a price-to-earnings-growth ratio of 1.63 and a beta of 0.35.

Becton, Dickinson and Company (NYSE:BDX - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The medical instruments supplier reported $3.43 EPS for the quarter, topping the consensus estimate of $3.00 by $0.43. Becton, Dickinson and Company had a net margin of 8.47% and a return on equity of 15.74%. On average, analysts anticipate that Becton, Dickinson and Company will post 14.43 earnings per share for the current year.

Becton, Dickinson and Company declared that its Board of Directors has approved a stock repurchase plan on Tuesday, January 28th that authorizes the company to buyback 10,000,000 outstanding shares. This buyback authorization authorizes the medical instruments supplier to reacquire shares of its stock through open market purchases. Stock buyback plans are usually an indication that the company's leadership believes its stock is undervalued.

Becton, Dickinson and Company Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 10th will be issued a dividend of $1.04 per share. The ex-dividend date of this dividend is Monday, March 10th. This represents a $4.16 annualized dividend and a dividend yield of 1.82%. Becton, Dickinson and Company's dividend payout ratio is 69.10%.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.